Oral micronized progesterone causes dizziness through its metabolite allopregnanolone, a potent GABA-A receptor modulator. Learn the neuropharmacology, risk factors, timing, and evidence-based strategies to reduce this common side effect.
Evidence-based dietary strategies to reduce dizziness caused by oral micronized progesterone (Prometrium). Covers meal timing, specific nutrients, hydration, and food-drug interactions, with clear notes on what is established versus what is plausible but unproven.
Evidence-based supplements to manage mood changes caused by oral micronized progesterone, including magnesium, vitamin B6, omega-3s, and adaptogens with clinical trial data.
Oral micronized progesterone causes sedation because the liver converts a portion of the dose to allopregnanolone, a neurosteroid that modulates GABA-A receptors. This explains the mechanism, the dose and route dependence, and how clinicians manage the effect.
Why sedation from oral micronized progesterone persists in some patients, what drives it biochemically, and evidence-based strategies to manage or eliminate it.
Evidence-based alternatives to testosterone cypionate that minimize or eliminate acne, plus strategies to manage androgen-driven breakouts during TRT.
Testosterone cypionate triggers acne by overstimulating sebaceous glands through DHT conversion and androgen receptor activation. Learn the biology, timeline, and evidence-based management strategies.
Evidence-based dietary strategies to reduce acne caused by testosterone cypionate, including anti-inflammatory foods, glycemic control, and nutrient-specific protocols reviewed by clinicians.
Evidence-based alternatives to testosterone cypionate that preserve male fertility, including clomiphene citrate, enclomiphene, hCG monotherapy, and nasal testosterone, with clinical trial data and dosing protocols.
Exogenous testosterone cypionate suppresses LH and FSH through hypothalamic-pituitary-gonadal axis feedback, halting intratesticular testosterone production and spermatogenesis. Learn the biology, timeline, and management strategies.
A clinical severity grading rubric for fertility suppression caused by testosterone cypionate, including mechanism, monitoring protocols, and management strategies for each grade.
Evidence-based supplements and adjuncts that may help preserve or restore fertility during testosterone cypionate therapy, with clinical trial data, doses, and practical guidance.
Evidence-based alternatives to testosterone cypionate that avoid or minimize gynecomastia risk, including non-aromatizing androgens, SERMs, aromatase inhibitors, and dose-optimization strategies.
A clinical grading system for gynecomastia caused by testosterone cypionate, covering mild to severe stages, when to intervene, and how to manage estrogen-driven breast tissue growth on TRT.
Gynecomastia from testosterone cypionate sometimes persists despite dose adjustments and estrogen blockers. Learn why it happens, when surgery becomes necessary, and evidence-based management strategies.
Know when gynecomastia from testosterone cypionate requires medical attention. Signs, timelines, and clinical thresholds that warrant contacting your prescriber.
Evidence-based alternatives to testosterone cypionate for men experiencing accelerated male-pattern hair loss on TRT, including 5-alpha reductase inhibitors, lower-DHT formulations, and non-testosterone options.
A clinical severity grading rubric for accelerated male-pattern hair loss caused by testosterone cypionate, including the Hamilton-Norwood scale, DHT-driven mechanisms, and evidence-based management strategies.
Learn when accelerated male-pattern hair loss from testosterone cypionate requires medical attention, what warning signs to watch for, and how your provider can help.
Learn to recognize high progesterone symptoms, which labs to request, what causes elevated levels, and the clinical next steps for diagnosis and treatment.
Learn which high progesterone symptoms require medical attention, what causes elevated progesterone, how it is diagnosed, and when you should worry enough to call your doctor.
High free testosterone by LC-MS/MS often signals PCOS but can indicate an adrenal or ovarian tumor. Learn which labs and next steps confirm the cause.
Learn the medical causes behind low testosterone symptoms, from primary hypogonadism to chronic illness and medication side effects, plus when to seek testing and treatment.
Recognize the signs of low testosterone, understand which lab tests confirm hypogonadism, and learn the evidence-based next steps for diagnosis and treatment.
Learn how to identify early perimenopause symptoms, which lab tests confirm the transition, and evidence-based next steps including HRT options and lifestyle interventions.
A clinical guide to medications that trigger or relieve postmenopausal symptoms, including hot flashes, vaginal atrophy, mood changes, and bone loss. Evidence-based drug classes, doses, and alternatives reviewed.
Understand what causes subclinical hypothyroidism symptoms, how the condition is diagnosed, when treatment is warranted, and which underlying factors drive elevated TSH with normal free T4.
What an elevated TSH with normal free T4 means, which labs confirm subclinical hypothyroidism, when treatment is generally recommended, and what monitoring looks like if it is not.
Evidence-based monitoring protocol for testosterone cypionate therapy in men aged 30, 49, including lab timing, hematocrit thresholds, cardiovascular screening, and fertility preservation.
Aetna (CVS Health) covers testosterone cypionate for diagnosed male hypogonadism with prior authorization. Learn formulary tier, step therapy rules, PA criteria, appeal steps, and cost-saving strategies.
Evidence-based guide to foods, supplements, and nutrients that interact with testosterone cypionate, including effects on absorption, metabolism, and clinical outcomes.
Evidence-based safety guide for testosterone cypionate use in geriatric men (65+), covering cardiovascular risk, prostate screening, polypharmacy, falls, and monitoring protocols.
Testosterone cypionate forms an IM depot, releases free testosterone via esterases, binds AR, converts to DHT or estradiol, and suppresses the HPG axis.
A clinical review of testosterone cypionate's patent history, generic availability, current formulations, and what prescribers and patients should know about access and cost in 2024 and beyond.
The Depo-Testosterone label lists pregnancy as a contraindication. It says testosterone may cause fetal harm and virilization of the female fetus.
A clinical review of real-world evidence for testosterone cypionate from patient registries, observational cohorts, and post-marketing studies, with PubMed-cited data on outcomes, safety, and long-term effects.
A country-by-country breakdown of testosterone cypionate's prescription status, controlled-substance scheduling, and availability across the US, EU, Canada, and the UK.
Evidence-based guide to testosterone cypionate storage conditions, chemical stability data, shelf life after opening, and proper handling to maintain potency and sterility.
TRICARE covers testosterone cypionate for diagnosed male hypogonadism. Learn about formulary tier, prior authorization requirements, step therapy, appeal options, and out-of-pocket costs for military beneficiaries.
Clinical guide to testosterone cypionate dosing in men aged 18-29, covering starting doses, titration, fertility preservation with hCG, and monitoring schedules backed by endocrine society guidelines.
Evidence-based safety profile of testosterone enanthate for men aged 30, 49, covering cardiovascular risk, hematologic monitoring, fertility impact, and FDA-mandated warnings.
Aetna (CVS Health) covers testosterone enanthate for diagnosed male hypogonadism with prior authorization. Learn formulary tier, step therapy requirements, PA criteria, and how to appeal a denial.
Compare testosterone enanthate pricing against cypionate, undecanoate, topical gels, oral capsules, nasal gel, and pellets. Includes per-month costs, insurance coverage patterns, and clinical equivalence data.
Evidence-based protocol for discontinuing testosterone enanthate, including tapering strategies, PCT options, HPTA recovery timelines, and monitoring labs.
Evidence-based guide to food and supplement interactions with testosterone enanthate, including effects on absorption, metabolism, and clinical outcomes.
Evidence-based safety guide for testosterone enanthate use in men aged 65 and older, covering cardiovascular risk, polycythemia, falls, drug interactions, and monitoring protocols.
Testosterone enanthate is testosterone with an oil-soluble ester that releases slowly after injection. Drugs@FDA lists Delatestryl approval in 1953.
A clinical deep-dive into testosterone enanthate manufacturing processes, supply chain dynamics, and the history of drug shortages affecting TRT patients in the United States.
MD-level explanation of how testosterone enanthate works, from ester hydrolysis and depot release through androgen receptor binding, gene transcription, and downstream physiologic effects. PubMed-cited.
State Medicaid coverage for testosterone enanthate varies widely. Learn which states cover it, prior authorization requirements, formulary tiers, appeal processes, and how to reduce out-of-pocket costs.
Medicare Advantage plans generally cover testosterone enanthate for diagnosed male hypogonadism. Learn about formulary tiers, prior authorization requirements, step therapy, and how to appeal a denial.
Clinical dosing guidance for testosterone enanthate in adults aged 50-64, including starting doses, titration protocols, monitoring labs, and cardiovascular safety considerations.
Evidence-based monitoring protocol for testosterone enanthate in men aged 50-64, covering lab timing, hematocrit thresholds, cardiovascular screening, PSA tracking, and bone density assessment.
Evidence-based safety profile of testosterone enanthate for men aged 50 to 64, covering cardiovascular risk, polypharmacy, PSA monitoring, and clinical trial data.
A clinician-grade review of testosterone enanthate's patent history, generic availability, FDA-approved formulations, and what the post-patent market means for prescribers and patients.
A clinician-focused review of testosterone enanthate real-world evidence from registries, VA databases, and long-term observational cohorts, including the T-Trials, TRAVERSE, and European registry data.
Evidence-based guide to testosterone enanthate use in transplant recipients, HIV/AIDS patients, and other special populations, with dosing, monitoring, and safety data from primary sources.
Levothyroxine can reverse the modest weight gain caused by hypothyroidism, but it is not a weight-loss drug. Here is what the clinical evidence actually shows about thyroid hormone replacement and body weight.
Learn the early and severe warning signs of low blood sugar (hypoglycemia), what causes drops below 70 mg/dL, and evidence-based solutions to treat and prevent episodes.
Evidence-based strategies to improve sleep quality and support healthy hormone levels, including cortisol, growth hormone, testosterone, thyroid hormones, and insulin sensitivity.